Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Design, properties, and effective use of the oral chelator L1 and other alpha-ketohydroxypyridines in the treatment of transfusional iron overload in thalassemia.

× No keyword cloud information.

12 in total

1. Oral iron chelation is here.

Authors: G J Kontoghiorghes
Journal: BMJ Date: 1991-11-23

2. Deferiprone reduces hemosiderin deposits in the brain of a patient with superficial siderosis.

Authors: M Levy; R H Llinas
Journal: AJNR Am J Neuroradiol Date: 2010-11-04 Impact factor: 3.825

Review 3. World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients.

Authors: Christina N Kontoghiorghe; Nicholas Andreou; Katerina Constantinou; George J Kontoghiorghes
Journal: World J Methodol Date: 2014-09-26

Review 4. Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.

Authors: Annita Kolnagou; Christina N Kontoghiorghe; George J Kontoghiorghes
Journal: World J Methodol Date: 2014-12-26

Review 5. Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.

Authors: George J Kontoghiorghes
Journal: Int J Mol Sci Date: 2022-06-16 Impact factor: 6.208

Review 6. Present status and future prospects of oral iron chelation therapy in thalassaemia and other diseases.

Authors: G J Kontoghiorghes
Journal: Indian J Pediatr Date: 1993 Jul-Aug Impact factor: 1.967

Review 7. Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors: George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal: Drug Saf Date: 2003 Impact factor: 5.606

Review 8. The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia.

Authors: George J Kontoghiorghes; Marios Kleanthous; Christina N Kontoghiorghe
Journal: Mediterr J Hematol Infect Dis Date: 2020-01-01 Impact factor: 2.576

9. Ocular abnormalities in multi-transfused beta-thalassemia patients.

Authors: Reza Jafari; Samira Heydarian; Hosein Karami; Mohammad Momeni Shektaei; Kiumars Noruzpour Dailami; Ahmad Ahmadzadeh Amiri; Majid Reza Sheikh Rezaee; Asad Allah Farrokh Far
Journal: Indian J Ophthalmol Date: 2015-09 Impact factor: 1.848

Review 10. Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.

Authors: George J Kontoghiorghes; Christina N Kontoghiorghe
Journal: Cells Date: 2020-06-12 Impact factor: 6.600